These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16097851)

  • 1. The opioidergic-alcohol link : implications for treatment.
    Modesto-Lowe V; Fritz EM
    CNS Drugs; 2005; 19(8):693-707. PubMed ID: 16097851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid systems and alcohol addiction.
    Herz A
    Psychopharmacology (Berl); 1997 Jan; 129(2):99-111. PubMed ID: 9040115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.
    Manzanares J; Ortiz S; Oliva JM; Pérez-Rial S; Palomo T
    Alcohol Alcohol; 2005; 40(1):25-34. PubMed ID: 15550451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
    Kato H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid involvement in alcohol drinking.
    Froehlich JC; Li TK
    Ann N Y Acad Sci; 1994 Oct; 739():156-67. PubMed ID: 7832469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alcohol dependence and opioid receptor -Pharmacological profile of nalmefene].
    Ohgi Y
    Nihon Yakurigaku Zasshi; 2020; 155(3):145-148. PubMed ID: 32378631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone.
    Zalewska-Kaszubska J; Gorska D; Dyr W; Czarnecka E
    Physiol Behav; 2008 Mar; 93(4-5):1005-10. PubMed ID: 18262210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and alcoholism.
    Oswald LM; Wand GS
    Physiol Behav; 2004 Apr; 81(2):339-58. PubMed ID: 15159175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of alcoholism: role of the endogenous opioid system.
    Gianoulakis C; de Waele JP
    Metab Brain Dis; 1994 Jun; 9(2):105-31. PubMed ID: 8072460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG
    Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.
    Gianoulakis C
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):33-42. PubMed ID: 9845036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid modulators for alcohol dependence.
    Hillemacher T; Heberlein A; Muschler MA; Bleich S; Frieling H
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1073-86. PubMed ID: 21651459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Place of the opioid system in biology and treatment of Alcohol Use Disorder].
    Nubukpo P
    Encephale; 2014 Dec; 40(6):457-67. PubMed ID: 25454364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
    Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
    Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in alcoholism:opioid peptides.
    Froehlich JC; Li TK
    Recent Dev Alcohol; 1993; 11():187-205. PubMed ID: 7901877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol-induced change in cardiac and endogenous opiate function and risk for alcoholism.
    Peterson JB; Pihl RO; Gianoulakis C; Conrod P; Finn PR; Stewart SH; LeMarquand DG; Bruce KR
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1542-52. PubMed ID: 8986201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.
    Gianoulakis C
    J Psychiatry Neurosci; 2001 Sep; 26(4):304-18. PubMed ID: 11590970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of naltrexone on human alcohol consumption.
    Swift RM
    J Clin Psychiatry; 1995; 56 Suppl 7():24-9. PubMed ID: 7673102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.